Recently the fusion gene, EML4-ALK, resulting from an inversion at 2p21/2p23, was found in 3–7% of non-small cell lung cancer (NSCLC) (Soda et al, 2007; Koivunen et al, 2008). This evidence concerns the gene EML4 and non-small cell lung carcinoma.